MELISSA LOEFFLER: Open Payments
NPI 1770602682 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,877 in 40 payments from 13 companies in 2025. Trend: 2023 $1,470 · 2024 $3,178 · 2025 $1,877
Food & beverage: $1,877
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $556 |
| Novartis Pharmaceuticals Corporation | 7 | $405 |
| Galderma Laboratories, L.P. | 6 | $205 |
| REVANCE THERAPEUTICS, INC. | 2 | $177 |
| Regeneron Healthcare Solutions, Inc. | 2 | $112 |
| Arcutis Biotherapeutics, Inc. | 2 | $106 |
| Lilly USA, LLC | 1 | $105 |
| PFIZER INC. | 1 | $78 |
| Incyte Corporation | 2 | $52 |
| GENZYME CORPORATION | 1 | $33 |
Products named: RINVOQ, SKYRIZI, COSENTYX, NEMLUVIO, DAXXIFY, DUPIXENT, Zoryve, EBGLYSS.
Industry payments across SC — which companies pay providers there.
